Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyper-IgM syndrome patients and carriers

Clinical Immunology and Immunopathology

Volumn 85, Issue 2, 1997, Pages 172-181

  O'Gorman, Maurice R G ^a   Zaas, David ^a   Paniagua, Mary ^a   Corrochano, Virginia ^a   Scholl, Paul R ^a   Pachman, Lauren M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; LIGAND; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULINEMIA M; IMMUNE DEFICIENCY; INFANT; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; X CHROMOSOME LINKAGE;

EID: 0030776074     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4422     Document Type: Article

References (29)

1. Conley, M. E., Molecular approaches to the analysis of X-linked immunodeficiencies. Annu. Rev. Immunol. 10, 215-238, 1992.
2. Notarangelo, L. D., Duse, M., and Ugazio, A. G., Immunodeficiency with hyper IgM (HIM). Immunodef. Rev. 3, 101-122, 1992.
3. Hayward, A. R., Levy, J., Facchetti, F., Notarangelo, L., Ochs, H. D., Etzioni, A., Bonnefoy, J.-Y., Cosyns, M., and Weinberg, A., Cholangiopathy and tumors of the pancreas, liver and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 158, 977-983, 1997.
4. Thomas, C., de Saint Basile, G., Le Deist, F., Theophile, D., Benkerrou, M., Haddad, E., Blanche, S., and Fischer, A., Brief Report: Correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. N. Engl. J. Med. 17, 333, 426-429, 1995.
5. Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, J., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., Fanslow, W. C., Belmont, J., and Spriggs, M. K., CD40 ligand gene defects responsible for X-linked hyper IgM Syndrome. Science 259, 990-993, 1993.
6. Arrufo, A., Farrington, M., Hollembaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., Roberts, R.L., Noelle, R.J., Ledbetter, J.A., Francke, U., and Ochs, H. D., The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72, 291-300, 1993.
7. DiSanto, J. P., Bonnefoy, J. Y., Gauchat, J. F., Fischer, A., and De Saint Basile, F., CD40 ligand mutations in X-linked immunodeficiency with hyper IgM. Nature (London) 361,539-543,1993.
8. Korthäuer, U., Graf, D., Mages, H. W., Briere, F., Padayachee, M., Malcolm, S., Ugazio, A. G., Notarangelo, L. D., Levinsky, R. J., and Kroczek, R. A., Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Mitare (London) 361, 539-541, 1993.
9. Fuleihan, R., Ramesh, N., Loh, R., Jabara, H. F., Rosen, S., Chatila, T., Fu, S. M., Stamenkovic, I., and Geha, R. S., Defective expression of the CD40 ligand in X chromosome linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sei. USA 90, 2170-2173, 1993.
10. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K.N., Macduff, B.M., Anderson, D.M., Gimpel, S.D., Davis-Smith, T., Maliszewski, C. R., Clark, E. A., Smith, C. A., Grabstein, K. H., Cosman, D., and Spriggs, M. K., Molecular and biological characterization of a murine ligand for CD40. Nature (London) 357, 80-82, 1992.
11. Hollenbaugh, D., Grosmaire, L. S., Kullas, G. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A-, and Aruffo, A., The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of p39 with B cell co-stimulatory activity. EMBO J. 11, 4313-4321, 1992.
12. Rousset, F., Garcia, E., and Banchereau, J., Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigens. J. Exp. Med. 173, 705-710, 1991.
13. Jabara, H. H., Fu, S. M., Geha, R. S., and Vercelli, D., CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172, 1861-1864, 1990.
14. Zhang, K, Clark, E. A., and Saxon, A., CD40 stimulation provides an IFN independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J. Immunol. 146, 1836-1842, 1991.
15. Defrance, T., Vanbervliet, B., Briere, F., Durand, I., Rousset, F., and Banchereau, J., Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175,671-682, 1992.
16. Armitage, R. A., Macduff, B. A., Spriggs, M. K, and Fasnslow, W. C., Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 150, 3671-3680, 1993.
17. Liu, Y.-D., Joshua, D. E., Williams, G. T., Smith, C. A., Gordon, J., and MacLennan, I. C. M., Mechanisms of antigen-driven selection in germinal centers. Nature (London) 342, 929-931, 1989.
18. Rousset, F., Garcia, E., DeFrance, T., Peronne, C., Vezzio, N., Hsu, D.-H., Kastelein, R., Moore, K. W., and Bancehereau, J., Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sei. USA 89, 1890-1893, 1992.
19. Grewal, I. S., Foellmer, H. G., Grewal, K. D., Xu, J., Hardardottir, F., Baron, J. L., Janeway, C. A., and Flavell, R. A., Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 272, 1864-1867, 1996.
20. Yang, Y., and Wilson, J. M., CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40. Science 273, 1862-1864, 1996.
21. Notarangelo, L. D., and Peitsch, M. C., CD401base: A database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol. Today 17, 511-516, 1996.
22. Conley, M. E., Larche, M., Bonagura, V. R., Lawton, A. R., III, Buckley, R. H., Fu, S. M., Coustan-Smith, E., Herrod, H. G., and Campana, D., Hyper IgM Syndrome associated with defective CD40-mediated B cell activation. J. Clin. Invest. 94,1404-1409, 1994.
23. Farrington, M., Grosmaire, L. S., Nonoyama, S., Fischer, S. H., Hollenbaugh, D., Ledbetter, J. A., Noelle, R. J., Aruffo, A., and Ochs, H. D., CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc. Natl. Acad. Sei. USA 91, 1099-1103, 1994.
24. O'Gorman, M. R., and Corrochano, V., Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease. Clin. Diagn. Lab. Immunol. 2, 227-232, 1995.
25. O'Gorman, M., McNally, A., Anderson, D., and Myones, B., A rapid whole blood lysis technique for the diagnosis of moderate or severe leukocye adhesion deficiency (LAD). Ann. NY Acad. Sei. 677, 427-431, 1993.
26. Seyama, K., Nonoyama, S., Hollenbaugh, D., Bajorath, J., Hasle, H., Kobayashi, R., Apter, A., Arrufo, A., and Ochs, H. D., X-linked Hyper IgM syndrome (XHIM) mutation analysis, CD40L function and clinical phenotype. J. Allergy Clin. Immunol. 99, S474, 1997.
27. Nonoyama, S., Penix, L. A., Edwards, C. P., Lewis, D. B., Ito, S., Aruffo, A., Wilson, C. B., and Ochs, H. D., Diminished expression of CD40 ligand by activated neonatal T cells. J. Clin. Invest. 95, 66-75, 1995.
28. Rieger, C. H. L., Moohr, J. W., and Rothberg, R. M., Correction of neutropenia associated with dysgammagloulinemia. Pediatrics 54, 508-511, 1974.
29. Almeida, C., Wu, W., Corrochano, V., O'Gorman, M. R., Pachman, L. M., and Scholl, P. R., Mutational analysis of X-linked hyper-IgM syndrome. J. Invest. Med. 44, 387A, 1996.